Bioscience Americas Financing
Bioscience Americas, Llc, Limited Liability Company just had published form D announcing $15.00 million equity financing. The date of first sale was 2015-10-28. Bioscience Americas was able to fundraise $950,000 so far. That is 6.33% of the financing offer. The total fundraising amount was $15.00 million. The financing form was filed on 2016-11-03. The reason for the financing was: unspecified. The fundraising still has about $14.05 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Bioscience Americas is based in Alabama. The firm’s business is Biotechnology. The form was signed by Eric Stoffers CEO. The company was incorporated in 2015. The filler’s address is: 2122 E Highland Avenue, Suite 265, Phoenix, Az, Arizona, 85016. Eric Cullen Stoffers is the related person in the form and it has address: 17822 N 45Th Avenue, Glendale, Az, Arizona, 85308. Link to Bioscience Americas Filing: 000156611416000151.
Analysis of Bioscience Americas Offering
On average, startups in the Biotechnology sector, sell 73.77% of the total offering amount. Bioscience Americas sold 6.33% of the offering. The fundraising is still open. The average financing size for companies in the Biotechnology industry is $3.08 million. The offering was 69.16% smaller than the average of $3.08 million. Of course this should not be taken as negative. Firms raise funds for different needs and reasons. The minimum investment for this financing was set at $10000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Bioscience Americas Also
The Form D signed by Eric Stoffers might help Bioscience Americas, Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.